143 related articles for article (PubMed ID: 16033949)
21. Clinical implications of CES2 RNA expression in neuroblastoma.
Uchida K; Otake K; Tanaka K; Hashimoto K; Saigusa S; Matsushita K; Koike Y; Inoue M; Ueeda M; Okugawa Y; Inoue Y; Mohri Y; Kusunoki M
J Pediatr Surg; 2013 Mar; 48(3):502-9. PubMed ID: 23480903
[TBL] [Abstract][Full Text] [Related]
22. The Relationship between
Ishimine M; Lee HC; Nakaoka H; Orita H; Kobayashi T; Mizuguchi K; Endo M; Inoue I; Sato K; Yokomizo T
Dis Markers; 2018; 2018():5280736. PubMed ID: 29651325
[TBL] [Abstract][Full Text] [Related]
23. Pharmacogenomic assessment of carboxylesterases 1 and 2.
Marsh S; Xiao M; Yu J; Ahluwalia R; Minton M; Freimuth RR; Kwok PY; McLeod HL
Genomics; 2004 Oct; 84(4):661-8. PubMed ID: 15475243
[TBL] [Abstract][Full Text] [Related]
24. Overexpression of carboxylesterase contributes to the attenuation of cyanotoxin microcystin-LR toxicity.
Takumi S; Shimono T; Ikema S; Hotta Y; Chigwechokha PK; Shiozaki K; Sugiyama Y; Hashimoto M; Furukawa T; Komatsu M
Comp Biochem Physiol C Toxicol Pharmacol; 2017 Apr; 194():22-27. PubMed ID: 28163251
[TBL] [Abstract][Full Text] [Related]
25. Difference in substrate specificity of carboxylesterase and arylacetamide deacetylase between dogs and humans.
Yoshida T; Fukami T; Kurokawa T; Gotoh S; Oda A; Nakajima M
Eur J Pharm Sci; 2018 Jan; 111():167-176. PubMed ID: 28966098
[TBL] [Abstract][Full Text] [Related]
26. Isolation and partial characterization of a cDNA encoding a rabbit liver carboxylesterase that activates the prodrug irinotecan (CPT-11).
Potter PM; Pawlik CA; Morton CL; Naeve CW; Danks MK
Cancer Res; 1998 Jun; 58(12):2646-51. PubMed ID: 9635592
[TBL] [Abstract][Full Text] [Related]
27. Characterization of Oncolytic Vaccinia Virus Harboring the Human IFNB1 and CES2 Transgenes.
Cho E; Islam SMBU; Jiang F; Park JE; Lee B; Kim ND; Hwang TH
Cancer Res Treat; 2020 Jan; 52(1):309-319. PubMed ID: 31401821
[TBL] [Abstract][Full Text] [Related]
28. CES2, ABCG2, TS and Topo-I primary and synchronous metastasis expression and clinical outcome in metastatic colorectal cancer patients treated with first-line FOLFIRI regimen.
Silvestris N; Simone G; Partipilo G; Scarpi E; Lorusso V; Brunetti AE; Maiello E; Paradiso A; Mangia A
Int J Mol Sci; 2014 Sep; 15(9):15767-77. PubMed ID: 25198900
[TBL] [Abstract][Full Text] [Related]
29. An improved human carboxylesterase for enzyme/prodrug therapy with CPT-11.
Wierdl M; Tsurkan L; Hyatt JL; Edwards CC; Hatfield MJ; Morton CL; Houghton PJ; Danks MK; Redinbo MR; Potter PM
Cancer Gene Ther; 2008 Mar; 15(3):183-92. PubMed ID: 18188187
[TBL] [Abstract][Full Text] [Related]
30. Mouse liver and kidney carboxylesterase (M-LK) rapidly hydrolyzes antitumor prodrug irinotecan and the N-terminal three quarter sequence determines substrate selectivity.
Xie M; Yang D; Wu M; Xue B; Yan B
Drug Metab Dispos; 2003 Jan; 31(1):21-7. PubMed ID: 12485949
[TBL] [Abstract][Full Text] [Related]
31. Biochemical and molecular analysis of carboxylesterase-mediated hydrolysis of cocaine and heroin.
Hatfield MJ; Tsurkan L; Hyatt JL; Yu X; Edwards CC; Hicks LD; Wadkins RM; Potter PM
Br J Pharmacol; 2010 Aug; 160(8):1916-28. PubMed ID: 20649590
[TBL] [Abstract][Full Text] [Related]
32. Functional characterization of seven single-nucleotide polymorphisms of the steroid sulfatase gene found in a Japanese population.
Matsumoto J; Ariyoshi N; Ishii I; Kitada M
J Hum Genet; 2013 May; 58(5):267-72. PubMed ID: 23466819
[TBL] [Abstract][Full Text] [Related]
33. Clinical implications of genetic variation in carboxylesterase drug metabolism.
Chen F; Zhang B; Parker RB; Laizure SC
Expert Opin Drug Metab Toxicol; 2018 Feb; 14(2):131-142. PubMed ID: 29264996
[TBL] [Abstract][Full Text] [Related]
34. Carboxylesterase-2 is a highly sensitive target of the antiobesity agent orlistat with profound implications in the activation of anticancer prodrugs.
Xiao D; Shi D; Yang D; Barthel B; Koch TH; Yan B
Biochem Pharmacol; 2013 Feb; 85(3):439-47. PubMed ID: 23228697
[TBL] [Abstract][Full Text] [Related]
35. Effect of Genetic Variation of
Dompreh A; Tang X; Zhou J; Yang H; Topletz A; Adu Ahwireng E; Antwi S; Enimil A; Langaee T; Peloquin CA; Court MH; Kwara A
Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29263072
[TBL] [Abstract][Full Text] [Related]
36. Secreted and tumour targeted human carboxylesterase for activation of irinotecan.
Oosterhoff D; Pinedo HM; van der Meulen IH; de Graaf M; Sone T; Kruyt FA; van Beusechem VW; Haisma HJ; Gerritsen WR
Br J Cancer; 2002 Sep; 87(6):659-64. PubMed ID: 12237777
[TBL] [Abstract][Full Text] [Related]
37. Near-infrared emission tracks inter-individual variability of carboxylesterase-2 via a novel molecular substrate.
Liu X; Li X; Dong P; Wu Z; Gao J; Wang Q
Mikrochim Acta; 2020 May; 187(6):313. PubMed ID: 32377952
[TBL] [Abstract][Full Text] [Related]
38. Intracellular conversion of irinotecan to its active form, SN-38, by native carboxylesterase in human non-small cell lung cancer.
Ohtsuka K; Inoue S; Kameyama M; Kanetoshi A; Fujimoto T; Takaoka K; Araya Y; Shida A
Lung Cancer; 2003 Aug; 41(2):187-98. PubMed ID: 12871782
[TBL] [Abstract][Full Text] [Related]
39. Regulation and expression of aberrant methylation on irinotecan metabolic genes CES2, UGT1A1 and GUSB in the in-vitro cultured colorectal cancer cells.
Xie FW; Peng YH; Chen X; Chen X; Li J; Yu ZY; Wang WW; Ouyang XN
Biomed Pharmacother; 2014 Feb; 68(1):31-7. PubMed ID: 24439671
[TBL] [Abstract][Full Text] [Related]
40. Overexpressed CES2 has prognostic value in CRC and knockdown CES2 reverses L-OHP-resistance in CRC cells by inhibition of the PI3K signaling pathway.
Zhang Y; Sun L; Sun Y; Chen Y; Wang X; Xu M; Chi P; Xu Z; Lu X
Exp Cell Res; 2020 Apr; 389(1):111856. PubMed ID: 31981591
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
